Pilot study of topical imiquimod combined with pembrolizumab for unresectable cutaneous metastatic melanoma - Poll - MDSpire

Pilot study of topical imiquimod combined with pembrolizumab for unresectable cutaneous metastatic melanoma

  • By

  • Joseph B. Parker

  • Richard W. Joseph

  • Vera J. Suman

  • Yiyi Yan

  • Ruqin Chen

  • June 10, 2026

  • 0 min

Share

Original Source(s)

Pilot study of topical imiquimod combined with pembrolizumab for unresectable cutaneous metastatic melanoma

  • by Joseph B. Parker, Richard W. Joseph, Vera J. Suman, Yiyi Yan, Ruqin Chen

  • June 10, 2026

Related Content

Correction: Converting an immunologically “cold” tumor: Exceptional response to cadonilimab plus chemotherapy in microsatellite-stable pancreatic cystadenocarcinoma

Long-term results after surgical resection of intrahepatic cholangiocarcinoma before and since the BILCAP era

The cells of origin of the chemotherapy-curable malignancies are highly sensitive to cytotoxic chemotherapy-mediated cell death